Arkolith/Insider Trading/INTI/Form 4

Ronald E Osman Irrevocable Trust III

10% OwnerInhibitor Therapeutics, Inc. (INTI) · full profile →Form 4 · filed Aug 29, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 11, 2023Grant(A)25K—$023.5M

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-23-045043) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML